VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
68 hedge funds and large institutions have $125M invested in Viracta Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
18% less capital invested
Capital invested by funds: $151M → $125M (-$26.8M)
26% less call options, than puts
Call options by funds: $497K | Put options by funds: $673K
Holders
68
Holding in Top 10
1
Calls
$497K
Puts
$673K
Top Buyers
| 1 | +$10.5M | |
| 2 | +$7.19M | |
| 3 | +$5.56M | |
| 4 |
Blackstone Inc
New York
|
+$2.35M |
| 5 |
State Street
Boston,
Massachusetts
|
+$920K |
Top Sellers
| 1 | -$4.49M | |
| 2 | -$2.1M | |
| 3 | -$936K | |
| 4 |
Goldman Sachs
New York
|
-$890K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$630K |